Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

653 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Colorectal Cancer OncoGuia.
Manchon Walsh P, Borràs JM, Ferro T, Espinàs JA; Colorectal Cancer OncoGuia Group. Manchon Walsh P, et al. Clin Transl Oncol. 2010 Mar;12(3):188-210. doi: 10.1007/s12094-010-0489-5. Clin Transl Oncol. 2010. PMID: 20231124 No abstract available.
Colorectal Cancer OncoGuia: surgical pathology report guidelines.
Sanjuán X, Salas A, Lloreta J, Manchon Walsh P; Colorectal Cancer OncoGuia Group. Sanjuán X, et al. Clin Transl Oncol. 2010 Mar;12(3):211-3. doi: 10.1007/s12094-010-0490-z. Clin Transl Oncol. 2010. PMID: 20231125 No abstract available.
Overcoming Resistance to Anti-EGFR Therapy in Colorectal Cancer.
Dienstmann R, Salazar R, Tabernero J. Dienstmann R, et al. Among authors: salazar r. Am Soc Clin Oncol Educ Book. 2015:e149-56. doi: 10.14694/EdBook_AM.2015.35.e149. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993166 Free article. Review.
Optimizing Anti-EGFR Therapy in Colorectal Cancer.
Salazar R, Ciardiello F. Salazar R, et al. Clin Cancer Res. 2015 Dec 15;21(24):5415-6. doi: 10.1158/1078-0432.CCR-15-1768. Epub 2015 Oct 13. Clin Cancer Res. 2015. PMID: 26463710
Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.
Azuara D, Santos C, Lopez-Doriga A, Grasselli J, Nadal M, Sanjuan X, Marin F, Vidal J, Montal R, Moreno V, Bellosillo B, Argiles G, Elez E, Dienstmann R, Montagut C, Tabernero J, Capellá G, Salazar R. Azuara D, et al. Among authors: salazar r. Mol Cancer Ther. 2016 May;15(5):1106-12. doi: 10.1158/1535-7163.MCT-15-0820. Epub 2016 Apr 1. Mol Cancer Ther. 2016. PMID: 27037411
Carcinoma-associated fibroblasts affect sensitivity to oxaliplatin and 5FU in colorectal cancer cells.
Gonçalves-Ribeiro S, Díaz-Maroto NG, Berdiel-Acer M, Soriano A, Guardiola J, Martínez-Villacampa M, Salazar R, Capellà G, Villanueva A, Martínez-Balibrea E, Molleví DG. Gonçalves-Ribeiro S, et al. Among authors: salazar r. Oncotarget. 2016 Sep 13;7(37):59766-59780. doi: 10.18632/oncotarget.11121. Oncotarget. 2016. PMID: 27517495 Free PMC article.
Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer.
Grasselli J, Elez E, Caratù G, Matito J, Santos C, Macarulla T, Vidal J, Garcia M, Viéitez JM, Paéz D, Falcó E, Lopez Lopez C, Aranda E, Jones F, Sikri V, Nuciforo P, Fasani R, Tabernero J, Montagut C, Azuara D, Dienstmann R, Salazar R, Vivancos A. Grasselli J, et al. Among authors: salazar r. Ann Oncol. 2017 Jun 1;28(6):1294-1301. doi: 10.1093/annonc/mdx112. Ann Oncol. 2017. PMID: 28368441 Free PMC article. Clinical Trial.
653 results